sepsis immunosuppression Treg
Showing 26 - 50 of 3,137
Sepsis Early EvaluatioN Through Rapid Ultrasound and veNous Gas
Recruiting
- Sepsis
- +2 more
-
Roma, Lazio, ItalyFondazione Policlinico Universitario "A. Gemelli", IRCCS; Emerge
Mar 24, 2023
Acute Kidney Injury Due to Sepsis Trial (TIN816 70 mg lyophilisate powder, Placebo)
Not yet recruiting
- Acute Kidney Injury Due to Sepsis
- TIN816 70 mg lyophilisate powder
- Placebo
- (no location specified)
Aug 10, 2023
Severe COVID-19 Disease Trial in Hackensack (RAPA-501-Allo off-the-shelf Therapy of COVID-19, Placebo)
Terminated
- Severe COVID-19 Disease
- RAPA-501-Allo off-the-shelf Therapy of COVID-19
- Placebo
-
Hackensack, New JerseyHackensack University Medical Center
Nov 3, 2021
Hypercholesterolemia Trial
Not yet recruiting
- Hypercholesterolemia
- (no location specified)
Dec 23, 2022
Clearance of Vasoactive Metabolites With Blood Purification
Not yet recruiting
- Critically Ill Patients
-
Garches, France
- +1 more
Oct 27, 2023
Lung Transplant Trial in Canada, United States (Tocilizumab, Placebo for Tocilizumab)
Not yet recruiting
- Lung Transplant
- Tocilizumab
- Placebo for Tocilizumab
-
Phoenix, Arizona
- +16 more
Sep 8, 2023
Heart Transplantation Trial in Madrid (Autologous thyTreg)
Recruiting
- Heart Transplantation
- Autologous thyTreg
-
Madrid, SpainHospital General Universitario Gregorio Marañon
Dec 5, 2022
Sepsis, Immune Dysfunction Trial in Guangzhou (electro-acupuncture)
Completed
- Sepsis
- Immune Dysfunction
- electro-acupuncture
-
Guangzhou, Guangdong, China2nd Affiliated Hospital of Guangzhou University of Chinese Medic
May 5, 2022
Kidney Transplantation Trial in Germany (MIC, Standard of Care)
Recruiting
- Kidney Transplantation
- MIC
- Standard of Care
-
Frankfurt, Germany
- +4 more
Oct 11, 2022
TIA, Carotid Artery Plaque, Carotid Atherosclerosis Trial in Cambridge (Interleukin-2 [IL-2], Standard care - Carotid
Not yet recruiting
- TIA
- +2 more
- Interleukin-2 [IL-2]
- Standard care - Carotid Endarterectomy
-
Cambridge, Cambridgeshire, United KingdomAddenbrookes Hospital
Aug 2, 2023
Acquired in Patients Hospitalized in Intensive Care Unit
Completed
- Patient Hospitalized in Intensive Care Unit
- blood sample
-
Rennes, FranceCHU de Rennes
Jan 17, 2022
Registration of Sepsis Patients in the Emergency Department
Not yet recruiting
- Sepsis
- no intervention
- (no location specified)
Sep 28, 2023
Nasal and Gut Microbiota Combined Clinical Events Predicts
Recruiting
- Sepsis
- Septic Shock
- gut and nasal microbiota detection
-
Dongguan, Guangdong, China
- +1 more
Jan 24, 2022
Sepsis on Quality Of Life, Vitality, Epigenome and Gene
Enrolling by invitation
- Sepsis
- Infection
- Exposure of interest: study DNA methylation (epigenetics) and gene expression (transcriptomics) of blood leukocytes
-
Groningen, NetherlandsUniversity Medical Center Groningen
Oct 4, 2021
IL-1ß and Its Receptor Antagonists in Treatment of Severe
Withdrawn
- Critical Illness
- Sepsis, Severe
- (no location specified)
Jun 13, 2022
IL-6 and Its Receptor Antagonists in Children's Severe Sepsis.
Withdrawn
- Critical Illness Sepsis, Severe
- (no location specified)
Jun 13, 2022
Strains, Acute Lymphoblastic Leukemia, Sepsis Trial in Mexico City (Simvastatin)
Recruiting
- Strains
- +2 more
-
Mexico City, MexicoHospital General de México "Dr. Eduardo Liceaga"
Jan 2, 2022
Prevalent Kidney Transplant Recipients Using Torque Teno Virus:
Not yet recruiting
- Kidney Transplant Infection
- +2 more
- Torque teno virus DNA measurement
- (no location specified)
Apr 19, 2023
Deficient T Regulatory Cell Function in Relapsing Remitting
Recruiting
- Relapse Remitting Multiple Sclerosis
-
Philadelphia, PennsylvaniaThomas Jefferson University
Jun 13, 2022
Septicemia Trial in Dijon (Blood sampling at inclusion, Blood sampling at 24 hours, Data collection)
Recruiting
- Septicemia
- Blood sampling at inclusion
- +2 more
-
Dijon, FranceChu Dijon Bourgogne
Sep 7, 2021
HO-1/CREB3 Modulates Golgi Stress in Patients With Sepsis
Not yet recruiting
- Sepsis
- nothing
-
Tianjin, Tianjin, ChinaTianjin Nankai Hospital
Sep 13, 2023
Surgical Injury Trial in Wuhan (Esketamine Hydrochloride 28 Mg in 0.2 mL NASAL SOLUTION [Spravato], 0.9% saline)
Not yet recruiting
- Surgical Injury
- Esketamine Hydrochloride 28 Mg in 0.2 mL NASAL SOLUTION [Spravato]
- 0.9% saline
-
Wuhan, Hubei, ChinaDepartment of Critical Care Medicine, Union Hospital, Tongji Med
Jul 12, 2022
Psoriasis, Atopic Dermatitis Trial in Taipei (UVB treatment)
Recruiting
- Psoriasis
- Atopic Dermatitis
- UVB treatment
-
Taipei, TaiwanNational Taiwan University Hospital
Nov 24, 2022
Sepsis Trial in Shanghai (Shen-Fu, Norepinephrine (NE),antibiotics,fluid resuscitation)
Recruiting
- Sepsis
- Shen-Fu
- Norepinephrine (NE),antibiotics,fluid resuscitation
-
Shanghai, Shanghai, ChinaRuijin Hospital
Nov 27, 2023